Back to Search
Start Over
Erratum to: 'Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain' [PAIN® 2013;154(10):1910–19]
- Source :
- Pain. 155:204
- Publication Year :
- 2014
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2014.
Details
- ISSN :
- 03043959
- Volume :
- 155
- Database :
- OpenAIRE
- Journal :
- Pain
- Accession number :
- edsair.doi...........a643d024fc0f424f2ace9a79760b3796
- Full Text :
- https://doi.org/10.1016/j.pain.2013.10.020